Literature DB >> 8955921

Involvement of the nucleus accumbens-ventral pallidal pathway in postictal behavior induced by a hippocampal afterdischarge in rats.

J Ma1, S M Brudzynski, L W Leung.   

Abstract

The hypothesis that postictal motor behaviors induced by a hippocampal afterdischarge (AD) are mediated by a pathway through the nucleus accumbens (NAC) and ventral pallidum (VP) was evaluated in freely moving rats. Tetanic stimulation of the hippocampal CA1 evoked an AD of 15-30 s and an increase in number of wet-dog shakes, face washes, rearings and locomotor activity. Bilateral injection of haloperidol (5 micrograms/side) or the selective dopamine D2 receptor antagonist, (+/-)-sulpiride (200 ng/side) before the hippocampal AD, into the NAC selectively reduced rearings and locomotor activity, but not the number of wet-dog shakes and face washes. Injection of R(+)-SCH-23390 (1 microgram/side), a D1 receptor antagonist, or rimcazole (0.4 mg/side), a sigma opioid receptor antagonist, into the NAC did not significantly alter postictal behaviors. Bilateral injection of muscimol (1 ng/side), a gamma-aminobutyric acid (GABAA) receptor agonist, into the VP before the AD significantly blocked all postictal behaviors. It is concluded that postictal locomotor activity induced by a hippocampal AD is mediated by activation of dopamine D2 receptors in the NAC and a pathway through the VP.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8955921     DOI: 10.1016/s0006-8993(96)00793-7

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  10 in total

1.  Lateral preoptic and ventral pallidal roles in locomotion and other movements.

Authors:  Suriya Subramanian; Rhett A Reichard; Hunter S Stevenson; Zachary M Schwartz; Kenneth P Parsley; Daniel S Zahm
Journal:  Brain Struct Funct       Date:  2018-04-26       Impact factor: 3.270

2.  The supramammillo-septal-hippocampal pathway mediates sensorimotor gating impairment and hyperlocomotion induced by MK-801 and ketamine in rats.

Authors:  Jingyi Ma; L Stan Leung
Journal:  Psychopharmacology (Berl)       Date:  2007-01-12       Impact factor: 4.530

Review 3.  A neurobiological basis for substance abuse comorbidity in schizophrenia.

Authors:  R A Chambers; J H Krystal; D W Self
Journal:  Biol Psychiatry       Date:  2001-07-15       Impact factor: 13.382

4.  Metabolic phenotyping of hand automatisms in mesial temporal lobe epilepsy.

Authors:  Jiajie Mo; Yao Wang; Jianguo Zhang; Lixin Cai; Qingzhu Liu; Wenhan Hu; Lin Sang; Chao Zhang; Xiu Wang; Xiaoqiu Shao; Kai Zhang
Journal:  EJNMMI Res       Date:  2022-06-03       Impact factor: 3.434

5.  Ketamine-induced deficit of auditory gating in the hippocampus of rats is alleviated by medial septal inactivation and antipsychotic drugs.

Authors:  Jingyi Ma; Siew Kian Tai; L Stan Leung
Journal:  Psychopharmacology (Berl)       Date:  2009-08-05       Impact factor: 4.530

6.  Dual Effects of Limbic Seizures on Psychosis-Relevant Behaviors Shown by Nucleus Accumbens Kindling in Rats.

Authors:  Jingyi Ma; L Stan Leung
Journal:  Brain Stimul       Date:  2016-05-18       Impact factor: 8.955

Review 7.  The role of the basal ganglia in the control of seizure.

Authors:  J Vuong; Annaelle Devergnas
Journal:  J Neural Transm (Vienna)       Date:  2017-08-01       Impact factor: 3.575

Review 8.  Medial Septum Modulates Consciousness and Psychosis-Related Behaviors Through Hippocampal Gamma Activity.

Authors:  L Stan Leung; Jingyi Ma
Journal:  Front Neural Circuits       Date:  2022-07-07       Impact factor: 3.342

9.  Evaluation of subcortical grey matter abnormalities in patients with MRI-negative cortical epilepsy determined through structural and tensor magnetic resonance imaging.

Authors:  Syu-Jyun Peng; Tomor Harnod; Jang-Zern Tsai; Ming-Dou Ker; Jun-Chern Chiou; Herming Chiueh; Chung-Yu Wu; Yue-Loong Hsin
Journal:  BMC Neurol       Date:  2014-05-14       Impact factor: 2.474

Review 10.  Animal models of epilepsy: use and limitations.

Authors:  Ludmyla Kandratavicius; Priscila Alves Balista; Cleiton Lopes-Aguiar; Rafael Naime Ruggiero; Eduardo Henrique Umeoka; Norberto Garcia-Cairasco; Lezio Soares Bueno-Junior; Joao Pereira Leite
Journal:  Neuropsychiatr Dis Treat       Date:  2014-09-09       Impact factor: 2.570

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.